Evidence map›Paper›PMID 10846073›Full record

ArticleJournal of virology2000

Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus.

H Jiang, Y G Cho, F Wang

Open access · greenAbstract readComparative Study
In one paragraph

Article in Journal of virology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. The Role of Gammaherpesviruses in Cancer Pathogenesis.Pathogens (Basel, Switzerland) · 2016
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Article
  8. Article
  9. Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells.Proceedings of the National Academy of Sciences of the United States of America · 2006
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Simian homologues of Epstein-Barr virus.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2001
    Review
  20. An Epstein-Barr-related herpesvirus from marmoset lymphomas.Proceedings of the National Academy of Sciences of the United States of America · 2001
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

H JiangDepartment of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Y G Cho
F Wang
Brigham and Women's Hospital · USHarvard University · US

Funding

PATHOGENESIS OF EPSTEIN BARR VIRUS INFECTIONR01CA068051 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI WANG, FREDERICK C. · 1995 to 2014
$5.8M
RECOMBINANT AND SIMIAN EPSTEIN-BARR VIRUSES FOR AIDSR01CA065319 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI WANG, FREDERICK C. · 1995 to 1998
–
NCI NIH HHS CA65319NCI NIH HHS CA68051NCI NIH HHS R01 CA068051
6 · The paper itself

Abstract

EBNA-3A, -3B, and -3C are three latent infection nuclear proteins important for Epstein-Barr virus (EBV)-induced B-cell immortalization and the immune response to EBV infection. All three are hypothesized to function as transcriptional transactivators, but little is known about their precise mechanism of action or their role in EBV pathogenesis. We have cloned and studied the three EBNA-3 homologues from a closely related lymphocryptovirus (LCV) which naturally infects rhesus monkeys. The rhesus LCV EBNA-3A, -3B, and -3C homologues have 37, 40, and 36% amino acid identity with the EBV genes, respectively. Function, as measured by in vitro assays, also appears to be conserved with the EBV genes, since the rhesus LCV EBNA-3s can interact with the transcription factor RBP-Jkappa and the rhesus LCV EBNA-3C encodes a Q/P-rich domain with transcriptional activation properties. In order to better understand the relationship between these EBV and rhesus LCV latent infection genes, we asked if the rhesus LCV EBNA-3 locus could be recombined into the EBV genome and if it could substitute for the EBV EBNA-3s when assayed for human B-cell immortalization. Recombination between the EBV genome and rhesus LCV DNA was reasonably efficient. However, these studies suggest that the rhesus LCV EBNA-3 locus was not completely interchangeable with the EBV EBNA-3 locus for B-cell immortalization and that at least one determinant of the species restriction for LCV-induced B-cell immortalization maps to the EBNA-3 locus. The overall conservation of EBNA-3 structure and function between EBV and rhesus LCV indicates that rhesus LCV infection of rhesus monkeys can provide an important animal model for studying the role of the EBNA-3 genes in LCV pathogenesis.

Indexed as

Nuclear ProteinsAmino Acid SequenceAnimalsAntigens, ViralChromosome MappingCloning, MolecularConserved SequenceDNA-Binding ProteinsEpstein-Barr Virus Nuclear AntigensGenes, ViralHerpesvirus 4, HumanHumansImmunoglobulin J Recombination Signal Sequence-Binding ProteinLymphocryptovirusMacaca mulattaMolecular Sequence DataAntigens, ViralDNA-Binding ProteinsEBNA-3C, epstein-barr virusEpstein-Barr Virus Nuclear AntigensImmunoglobulin J Recombination Signal Sequence-Binding Proteinlymphocryptovirus nuclear antigen 3Alymphocryptovirus nuclear antigen 3Blymphocryptovirus nuclear antigen 3CNuclear ProteinsRBPJ protein, humanTrans-ActivatorsViral Proteins

Identifiers

PMID10846073
PMCPMC112088
OpenAlexW2124411457

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.